Literature DB >> 12581902

The use of clustering software for the classification of comparative genomic hybridization data. an analysis of 109 malignant fibrous histiocytomas.

Frédéric Chibon1, Odette Mariani, Aline Mairal, Josette Derré, Jean-Michel Coindre, Philippe Terrier, Réal Lagacé, Xavier Sastre, Alain Aurias.   

Abstract

Malignant fibrous histiocytoma (MFH) is considered the most frequent soft-tissue sarcoma of late adult life. Nevertheless, the validity of this entity has been recurrently questioned by pathologists. Preliminary analyses by comparative genomic hybridization (CGH) of series of MFH have suggested that this tumor group is heterogeneous at the genomic level, and that at least two main genetic subgroups exist. We report an analysis by CGH of a large series of 109 MFH and on the use of clustering software for an objective classification of these tumors. We confirm our preliminary CGH results and demonstrate that two main clusters of tumors are present in the series analyzed.

Entities:  

Mesh:

Year:  2003        PMID: 12581902     DOI: 10.1016/s0165-4608(02)00664-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity.

Authors:  Frédéric Chibon; Pauline Lagarde; Sébastien Salas; Gaëlle Pérot; Véronique Brouste; Franck Tirode; Carlo Lucchesi; Aurélien de Reynies; Audrey Kauffmann; Binh Bui; Philippe Terrier; Sylvie Bonvalot; Axel Le Cesne; Dominique Vince-Ranchère; Jean-Yves Blay; Françoise Collin; Louis Guillou; Agnès Leroux; Jean-Michel Coindre; Alain Aurias
Journal:  Nat Med       Date:  2010-06-27       Impact factor: 53.440

2.  Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics.

Authors:  Gaëlle Pérot; Frédéric Chibon; Audrey Montero; Pauline Lagarde; Hugues de Thé; Philippe Terrier; Louis Guillou; Dominique Ranchère; Jean-Michel Coindre; Alain Aurias
Journal:  Am J Pathol       Date:  2010-10       Impact factor: 4.307

Review 3.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.

Authors:  Franck Toledo; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

4.  Genome remodeling upon mesenchymal tumor cell fusion contributes to tumor progression and metastatic spread.

Authors:  Lydia Lartigue; Candice Merle; Pauline Lagarde; Lucile Delespaul; Tom Lesluyes; Sophie Le Guellec; Gaelle Pérot; Laura Leroy; Jean-Michel Coindre; Frédéric Chibon
Journal:  Oncogene       Date:  2020-04-02       Impact factor: 9.867

5.  Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas.

Authors:  Sara Martoreli Silveira; Rolando Andre Rios Villacis; Fabio Albuquerque Marchi; Mateus de Camargo Barros Filho; Sandra Aparecida Drigo; Cristovam Scapulatempo Neto; Ademar Lopes; Isabela Werneck da Cunha; Silvia Regina Rogatto
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

6.  Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.

Authors:  Anne-Lise Peille; Veronique Brouste; Audrey Kauffmann; Pauline Lagarde; Valerie Le Morvan; Jean-Michel Coindre; Frederic Chibon; Laurence Bresson-Bepoldin
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.